SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:kth-306416"
 

Sökning: onr:"swepub:oai:DiVA.org:kth-306416" > Lysine demethylase ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00007556naa a2200529 4500
001oai:DiVA.org:kth-306416
003SwePub
008211216s2021 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-3064162 URI
024a https://doi.org/10.15252/embr.2020509222 DOI
040 a (SwePub)kth
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Zhao, Li-Juanu Collaborat Innovat Ctr New Drug Res & Safety Eval, State Key Lab Esophageal Canc Prevent & Treatment, Key Lab Adv Drug Preparat Technol, Minist Educ China, Zhengzhou, Henan, Peoples R China.;Zhengzhou Univ, Acad Med Sci, Key Lab Henan Prov Drug Qual & Evaluat, Inst Drug Discovery & Dev,Sch Pharmaceut Sci, Zhengzhou, Peoples R China.4 aut
2451 0a Lysine demethylase LSD1 delivered via small extracellular vesicles promotes gastric cancer cell stemness
264 c 2021-05-31
264 1b EMBO,c 2021
338 a print2 rdacarrier
500 a QC 20211216
520 a Several studies have examined the functions of nucleic acids in small extracellular vesicles (sEVs). However, much less is known about the protein cargos of sEVs and their functions in recipient cells. This study demonstrates the presence of lysine-specific demethylase 1 (LSD1), which is the first identified histone demethylase, in the culture medium of gastric cancer cells. We show that sEVs derived from gastric cancer cells and the plasma of patients with gastric cancer harbor LSD1. The shuttling of LSD1-containing sEVs from donor cells to recipient gastric cancer cells promotes cancer cell stemness by positively regulating the expression of Nanog, OCT4, SOX2, and CD44. Additionally, sEV-delivered LSD1 suppresses oxaliplatin response of recipient cells in vitro and in vivo, whereas LSD1-depleted sEVs do not. Taken together, we demonstrate that LSD1-loaded sEVs can promote stemness and chemoresistance to oxaliplatin. These findings suggest that the LSD1 content of sEV could serve as a biomarker to predict oxaliplatin response in gastric cancer patients.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Cell- och molekylärbiologi0 (SwePub)301082 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Cell and Molecular Biology0 (SwePub)301082 hsv//eng
653 a gastric cancer
653 a LSD1
653 a small extracellular vesicles
653 a stemness
700a Li, Ying-Yingu Collaborat Innovat Ctr New Drug Res & Safety Eval, State Key Lab Esophageal Canc Prevent & Treatment, Key Lab Adv Drug Preparat Technol, Minist Educ China, Zhengzhou, Henan, Peoples R China.;Zhengzhou Univ, Acad Med Sci, Key Lab Henan Prov Drug Qual & Evaluat, Inst Drug Discovery & Dev,Sch Pharmaceut Sci, Zhengzhou, Peoples R China.4 aut
700a Zhang, Yu-Tongu Collaborat Innovat Ctr New Drug Res & Safety Eval, State Key Lab Esophageal Canc Prevent & Treatment, Key Lab Adv Drug Preparat Technol, Minist Educ China, Zhengzhou, Henan, Peoples R China.;Zhengzhou Univ, Acad Med Sci, Key Lab Henan Prov Drug Qual & Evaluat, Inst Drug Discovery & Dev,Sch Pharmaceut Sci, Zhengzhou, Peoples R China.4 aut
700a Fan, Qi-Qiu Collaborat Innovat Ctr New Drug Res & Safety Eval, State Key Lab Esophageal Canc Prevent & Treatment, Key Lab Adv Drug Preparat Technol, Minist Educ China, Zhengzhou, Henan, Peoples R China.;Zhengzhou Univ, Acad Med Sci, Key Lab Henan Prov Drug Qual & Evaluat, Inst Drug Discovery & Dev,Sch Pharmaceut Sci, Zhengzhou, Peoples R China.4 aut
700a Ren, Hong-Meiu Collaborat Innovat Ctr New Drug Res & Safety Eval, State Key Lab Esophageal Canc Prevent & Treatment, Key Lab Adv Drug Preparat Technol, Minist Educ China, Zhengzhou, Henan, Peoples R China.;Zhengzhou Univ, Acad Med Sci, Key Lab Henan Prov Drug Qual & Evaluat, Inst Drug Discovery & Dev,Sch Pharmaceut Sci, Zhengzhou, Peoples R China.4 aut
700a Zhang, Chengu KTH,Science for Life Laboratory, SciLifeLab,Systembiologi4 aut0 (Swepub:kth)u1ww5kvp
700a Mardinoglu, Adilu KTH,Science for Life Laboratory, SciLifeLab,Systembiologi,Kings Coll London, Ctr Host Microbiome Interact, Fac Dent Oral & Craniofacial Sci, London, England.4 aut0 (Swepub:kth)u1t8kmr6
700a Chen, Wen-Chaou Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Gastrointestinal Surg, Zhengzhou, Peoples R China.4 aut
700a Pang, Jing-Ruu Collaborat Innovat Ctr New Drug Res & Safety Eval, State Key Lab Esophageal Canc Prevent & Treatment, Key Lab Adv Drug Preparat Technol, Minist Educ China, Zhengzhou, Henan, Peoples R China.;Zhengzhou Univ, Acad Med Sci, Key Lab Henan Prov Drug Qual & Evaluat, Inst Drug Discovery & Dev,Sch Pharmaceut Sci, Zhengzhou, Peoples R China.4 aut
700a Shen, Dan-Danu Collaborat Innovat Ctr New Drug Res & Safety Eval, State Key Lab Esophageal Canc Prevent & Treatment, Key Lab Adv Drug Preparat Technol, Minist Educ China, Zhengzhou, Henan, Peoples R China.;Zhengzhou Univ, Acad Med Sci, Key Lab Henan Prov Drug Qual & Evaluat, Inst Drug Discovery & Dev,Sch Pharmaceut Sci, Zhengzhou, Peoples R China.4 aut
700a Wang, Jun-Weiu Collaborat Innovat Ctr New Drug Res & Safety Eval, State Key Lab Esophageal Canc Prevent & Treatment, Key Lab Adv Drug Preparat Technol, Minist Educ China, Zhengzhou, Henan, Peoples R China.;Zhengzhou Univ, Acad Med Sci, Key Lab Henan Prov Drug Qual & Evaluat, Inst Drug Discovery & Dev,Sch Pharmaceut Sci, Zhengzhou, Peoples R China.4 aut
700a Zhao, Long-Feiu Collaborat Innovat Ctr New Drug Res & Safety Eval, State Key Lab Esophageal Canc Prevent & Treatment, Key Lab Adv Drug Preparat Technol, Minist Educ China, Zhengzhou, Henan, Peoples R China.;Zhengzhou Univ, Acad Med Sci, Key Lab Henan Prov Drug Qual & Evaluat, Inst Drug Discovery & Dev,Sch Pharmaceut Sci, Zhengzhou, Peoples R China.4 aut
700a Zhang, Jian-Yingu Zhengzhou Univ, Henan Inst Med & Pharmaceut Sci, Zhengzhou, Peoples R China.4 aut
700a Wang, Zhen-Yau Zhengzhou Univ, Inst Drug Discovery & Dev, Key Lab Runliang Antiviral Medicines Res & Dev, Zhengzhou, Peoples R China.4 aut
700a Zheng, Yi-Chaou Collaborat Innovat Ctr New Drug Res & Safety Eval, State Key Lab Esophageal Canc Prevent & Treatment, Key Lab Adv Drug Preparat Technol, Minist Educ China, Zhengzhou, Henan, Peoples R China.;Zhengzhou Univ, Acad Med Sci, Key Lab Henan Prov Drug Qual & Evaluat, Inst Drug Discovery & Dev,Sch Pharmaceut Sci, Zhengzhou, Peoples R China.4 aut
700a Liu, Hong-Minu Collaborat Innovat Ctr New Drug Res & Safety Eval, State Key Lab Esophageal Canc Prevent & Treatment, Key Lab Adv Drug Preparat Technol, Minist Educ China, Zhengzhou, Henan, Peoples R China.;Zhengzhou Univ, Acad Med Sci, Key Lab Henan Prov Drug Qual & Evaluat, Inst Drug Discovery & Dev,Sch Pharmaceut Sci, Zhengzhou, Peoples R China.4 aut
710a Collaborat Innovat Ctr New Drug Res & Safety Eval, State Key Lab Esophageal Canc Prevent & Treatment, Key Lab Adv Drug Preparat Technol, Minist Educ China, Zhengzhou, Henan, Peoples R China.;Zhengzhou Univ, Acad Med Sci, Key Lab Henan Prov Drug Qual & Evaluat, Inst Drug Discovery & Dev,Sch Pharmaceut Sci, Zhengzhou, Peoples R China.b Science for Life Laboratory, SciLifeLab4 org
773t EMBO Reportsd : EMBOg 22:8q 22:8x 1469-221Xx 1469-3178
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-306416
8564 8u https://doi.org/10.15252/embr.202050922

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy